[go: up one dir, main page]

Andrasina et al., 2021 - Google Patents

Thermal ablation and transarterial chemoembolization are characterized by changing dynamics of circulating MicroRNAs

Andrasina et al., 2021

Document ID
14852862147974068437
Author
Andrasina T
Juracek J
Zavadil J
Cechova B
Rohan T
Vesela P
Paldor M
Slaby O
Goldberg S
Publication year
Publication venue
Journal of Vascular and Interventional Radiology

External Links

Snippet

Purpose To determine whether the levels of circulating microRNAs (miRNAs) are altered in patients undergoing thermal ablation and chemoembolization and whether these changes are predictive of a clinical outcome. Material and Methods This prospective study consisted …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Hybridisation probes
    • C12Q1/6883Hybridisation probes for diseases caused by alterations of genetic material
    • C12Q1/6886Hybridisation probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/574Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57419Specifically defined cancers of colon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • A61K31/282Platinum compounds

Similar Documents

Publication Publication Date Title
Lan et al. Serum exosomal lncRNA XIST is a potential non‐invasive biomarker to diagnose recurrence of triple‐negative breast cancer
Barfeld et al. Androgen-regulated metabolism and biosynthesis in prostate cancer
Le Calvez-Kelm et al. KRAS mutations in blood circulating cell-free DNA: a pancreatic cancer case-control
Cheng et al. Circulating miR-106a is a novel prognostic and lymph node metastasis indicator for cholangiocarcinoma
Fang et al. Plasma MicroRNA pair panels as novel biomarkers for detection of early stage breast cancer
Soliman et al. Serum circulating cell free DNA as potential diagnostic and prognostic biomarker in non small cell lung cancer
Andrasina et al. Thermal ablation and transarterial chemoembolization are characterized by changing dynamics of circulating MicroRNAs
Brandes et al. Adult neuroectodermal tumors of posterior fossa (medulloblastoma) and of supratentorial sites (stPNET)
Dawe et al. Brain metastases in non–small-cell lung cancer
Ganapathy-Kanniappan et al. Human hepatocellular carcinoma in a mouse model: assessment of tumor response to percutaneous ablation by using glyceraldehyde-3-phosphate dehydrogenase antagonists
Theiss et al. Gastrointestinal stromal tumors of the stomach and esophagus
Zitt et al. Circulating Cell‐Free DNA in Plasma of Locally Advanced Rectal Cancer Patients Undergoing Preoperative Chemoradiation: A Potential Diagnostic Tool for Therapy Monitoring
Ali et al. Circulating miR-26a, miR-106b, miR-107 and miR-133b stratify hepatocellular carcinoma patients according to their response to transarterial chemoembolization
WO2018204725A1 (en) Theranostic tools for management of pancreatic cancer and its precursors
Maleckaite et al. DNA methylation of metallothionein genes is associated with the clinical features of renal cell carcinoma
Ohaegbulam et al. The multidisciplinary management of cholangiocarcinoma
Bhangu et al. Circulating cell-free DNA in plasma of colorectal cancer patients-A potential biomarker for tumor burden
Liang et al. CyclinD1 is a new target gene of tumor suppressor miR-520e in breast cancer
Liu et al. Changes of serum miR34a expression during neoadjuvant chemotherapy predict the treatment response and prognosis in stage II/III breast cancer
Wang et al. Predictive significance of serum level of vascular endothelial growth factor in gastric cancer patients
Masuda et al. Efficacy of platinum combination chemotherapy after first-line gefitinib treatment in non-small cell lung cancer patients harboring sensitive EGFR mutations
Zhang et al. Research progress review on long non-coding RNA in colorectal cancer.
Hur et al. Adenosine triphosphate-based chemotherapy response assay-guided chemotherapy in unresectable colorectal liver metastasis
Improta et al. Coexistence of two different mutations in codon 12 of the Kras gene in colorectal cancer: Report of a case supporting the concept of tumoral heterogeneity
Luo et al. Serum microRNA-199a/b-3p as a predictive biomarker for treatment response in patients with hepatocellular carcinoma undergoing transarterial chemoembolization